• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>NCI

NCI

NCI Inc Class A NCIT

Last Price$9.14Day Change (%)-0.98%
Open Price$9.27Day Change ($)-0.09
Day Range8.79–9.2752-Week Range4.83–13.12

As of Fri 08/29/2014 02:54 PM EST | USD

  1. Tau Therapeutics and Xdynia Merge to Form Cavion

    Tau Therapeutics and Xdynia Merge to Form Cavion

  2. MultiCell Technologies Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer

    MultiCell Technologies Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer

  3. Research and Markets: Global and Chinese MLCC Electronic Ceramics Industry Report, 2013-2015

    Research and Markets: Global and Chinese MLCC Electronic Ceramics Industry Report, 2013-2015

  4. Data Published by Researchers from The Scripps Research Institute Demonstrate Potential for MYC Inhibitor Licensed by Sorrento Therapeutics

    Data Published by Researchers from The Scripps Research Institute Demonstrate Potential for MYC Inhibitor Licensed by Sorrento Therapeutics

  5. Concordia Healthcare Corp. announces first patients enrolled in Phase 2 clinical trial using Photodynamic Therapy with PHOTOFRIN(R) for patients with mesothelioma

    Concordia Healthcare Corp. announces first patients enrolled in Phase 2 clinical trial using Photodynamic Therapy with PHOTOFRIN(R) for patients with mesothelioma

  6. Oncothyreon Announces Acquisition of Alpine Biosciences

    Oncothyreon Announces Acquisition of Alpine Biosciences

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.